WEST CONSHOHOCKEN, PA – Recent filings with the Securities and Exchange Commission reveal that Robert E. Waltermire, Senior Vice President and Chief of Pharmaceutical Development at Madrigal Pharmaceuticals, Inc. (NASDAQ:), sold shares in the company. On June 12, 2024, Waltermire sold 2,000 shares of common stock at an average price of $285 per share, totaling $570,000.
The same SEC filings…
Shop Women’s Swimwear for Up to 40% Off
SHOP NOW
Madrigal Pharmaceuticals senior VP sells $570,000 in stock By Investing.com
Business News
